Transcatheter Valve Replacement Skips Sticker Shock
April 6, 2011|Hospitalist News (Archived)
Author and Disclosure Information
Major Finding: The lifetime incremental cost of transcatheter aortic valve replacement per patient was $79,837, and the lifetime incremental gain in life expectancy was 1.59 years.
Data Source: Economic analysis of 358 inoperable high-risk patients with severe aortic stenosis in the PARTNER trial.
Disclosures: Edwards Lifesciences provided grant support for the analysis.
FROM THE ANNUAL MEETING OF THE AMERICAN COLLEGE OF CARDIOLOGY
Edwards Lifesciences provided grant support for the analysis.
